nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—PTK2—Netrin mediated repulsion signals—DCC—ureter cancer	0.0325	0.074	CbGpPWpGaD
Bosutinib—PTK2—DCC mediated attractive signaling—DCC—ureter cancer	0.0249	0.0566	CbGpPWpGaD
Bosutinib—FYN—Netrin mediated repulsion signals—DCC—ureter cancer	0.0236	0.0536	CbGpPWpGaD
Bosutinib—PRKCQ—Netrin-1 signaling—DCC—ureter cancer	0.0188	0.0429	CbGpPWpGaD
Bosutinib—FYN—DCC mediated attractive signaling—DCC—ureter cancer	0.018	0.0409	CbGpPWpGaD
Bosutinib—SRC—Netrin mediated repulsion signals—DCC—ureter cancer	0.0174	0.0395	CbGpPWpGaD
Bosutinib—STK26—Apoptosis—DCC—ureter cancer	0.0173	0.0394	CbGpPWpGaD
Bosutinib—STK24—Apoptosis—DCC—ureter cancer	0.0147	0.0335	CbGpPWpGaD
Bosutinib—SRC—DCC mediated attractive signaling—DCC—ureter cancer	0.0133	0.0302	CbGpPWpGaD
Bosutinib—PTK2—Netrin-mediated signaling events—DCC—ureter cancer	0.0128	0.0292	CbGpPWpGaD
Bosutinib—YES1—Netrin-mediated signaling events—DCC—ureter cancer	0.0127	0.0288	CbGpPWpGaD
Bosutinib—BMX—Apoptosis—DCC—ureter cancer	0.012	0.0273	CbGpPWpGaD
Bosutinib—CASK—Cell-Cell communication—DCC—ureter cancer	0.0109	0.0248	CbGpPWpGaD
Bosutinib—PTK2—Netrin-1 signaling—DCC—ureter cancer	0.0103	0.0235	CbGpPWpGaD
Bosutinib—MAP2K2—Netrin-mediated signaling events—DCC—ureter cancer	0.00988	0.0225	CbGpPWpGaD
Bosutinib—FYN—Netrin-mediated signaling events—DCC—ureter cancer	0.00929	0.0211	CbGpPWpGaD
Bosutinib—MAP2K1—Netrin-mediated signaling events—DCC—ureter cancer	0.00924	0.021	CbGpPWpGaD
Bosutinib—TLK1—renal system—ureter cancer	0.00869	0.0155	CbGeAlD
Bosutinib—SIK2—renal system—ureter cancer	0.00845	0.0151	CbGeAlD
Bosutinib—FRK—renal system—ureter cancer	0.00824	0.0147	CbGeAlD
Bosutinib—CLK3—renal system—ureter cancer	0.00804	0.0143	CbGeAlD
Bosutinib—DSTYK—urethra—ureter cancer	0.0079	0.0141	CbGeAlD
Bosutinib—BMX—urethra—ureter cancer	0.0079	0.0141	CbGeAlD
Bosutinib—SRMS—renal system—ureter cancer	0.00769	0.0137	CbGeAlD
Bosutinib—EIF2AK1—urethra—ureter cancer	0.00763	0.0136	CbGeAlD
Bosutinib—FYN—Netrin-1 signaling—DCC—ureter cancer	0.00747	0.017	CbGpPWpGaD
Bosutinib—SRMS—kidney—ureter cancer	0.00743	0.0133	CbGeAlD
Bosutinib—VRK2—urethra—ureter cancer	0.0074	0.0132	CbGeAlD
Bosutinib—SYK—renal system—ureter cancer	0.00739	0.0132	CbGeAlD
Bosutinib—CDK2—renal system—ureter cancer	0.00732	0.0131	CbGeAlD
Bosutinib—SYK—urethra—ureter cancer	0.00726	0.0129	CbGeAlD
Bosutinib—STK26—renal system—ureter cancer	0.00725	0.0129	CbGeAlD
Bosutinib—SYK—kidney—ureter cancer	0.00714	0.0127	CbGeAlD
Bosutinib—STK26—urethra—ureter cancer	0.00712	0.0127	CbGeAlD
Bosutinib—CDK2—kidney—ureter cancer	0.00708	0.0126	CbGeAlD
Bosutinib—STK26—kidney—ureter cancer	0.00701	0.0125	CbGeAlD
Bosutinib—SRC—Netrin-mediated signaling events—DCC—ureter cancer	0.00685	0.0156	CbGpPWpGaD
Bosutinib—WEE1—urethra—ureter cancer	0.00682	0.0122	CbGeAlD
Bosutinib—DMPK—urethra—ureter cancer	0.00682	0.0122	CbGeAlD
Bosutinib—STK25—renal system—ureter cancer	0.00663	0.0118	CbGeAlD
Bosutinib—PRKCQ—Apoptosis—DCC—ureter cancer	0.00663	0.0151	CbGpPWpGaD
Bosutinib—STK25—urethra—ureter cancer	0.00652	0.0116	CbGeAlD
Bosutinib—PLK2—renal system—ureter cancer	0.00645	0.0115	CbGeAlD
Bosutinib—PLK2—urethra—ureter cancer	0.00633	0.0113	CbGeAlD
Bosutinib—PLK2—kidney—ureter cancer	0.00623	0.0111	CbGeAlD
Bosutinib—CAMK1D—urethra—ureter cancer	0.00599	0.0107	CbGeAlD
Bosutinib—STK24—urethra—ureter cancer	0.00592	0.0106	CbGeAlD
Bosutinib—FER—urethra—ureter cancer	0.00572	0.0102	CbGeAlD
Bosutinib—SRC—Netrin-1 signaling—DCC—ureter cancer	0.00551	0.0125	CbGpPWpGaD
Bosutinib—MAP4K2—urethra—ureter cancer	0.00542	0.00968	CbGeAlD
Bosutinib—ROCK1—renal system—ureter cancer	0.00538	0.00959	CbGeAlD
Bosutinib—CHEK2—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00529	0.012	CbGpPWpGaD
Bosutinib—PTK2B—Cell-Cell communication—DCC—ureter cancer	0.00525	0.0119	CbGpPWpGaD
Bosutinib—BMPR2—renal system—ureter cancer	0.00522	0.00932	CbGeAlD
Bosutinib—ROCK1—kidney—ureter cancer	0.0052	0.00927	CbGeAlD
Bosutinib—BMPR2—urethra—ureter cancer	0.00513	0.00915	CbGeAlD
Bosutinib—EPHB3—urethra—ureter cancer	0.00509	0.00908	CbGeAlD
Bosutinib—STK36—urethra—ureter cancer	0.00509	0.00908	CbGeAlD
Bosutinib—BMPR2—kidney—ureter cancer	0.00505	0.00901	CbGeAlD
Bosutinib—MERTK—urethra—ureter cancer	0.00503	0.00898	CbGeAlD
Bosutinib—MAP4K4—renal system—ureter cancer	0.00503	0.00897	CbGeAlD
Bosutinib—BCR—renal system—ureter cancer	0.00499	0.0089	CbGeAlD
Bosutinib—MAP4K4—urethra—ureter cancer	0.00494	0.00881	CbGeAlD
Bosutinib—BCR—urethra—ureter cancer	0.0049	0.00875	CbGeAlD
Bosutinib—MAP3K12—urethra—ureter cancer	0.00487	0.00869	CbGeAlD
Bosutinib—MAP4K4—kidney—ureter cancer	0.00486	0.00867	CbGeAlD
Bosutinib—MAP2K1—renal system—ureter cancer	0.00485	0.00866	CbGeAlD
Bosutinib—CSK—renal system—ureter cancer	0.00482	0.0086	CbGeAlD
Bosutinib—CSNK1A1—renal system—ureter cancer	0.00479	0.00855	CbGeAlD
Bosutinib—CDK2—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00477	0.0109	CbGpPWpGaD
Bosutinib—CLK1—renal system—ureter cancer	0.00476	0.00849	CbGeAlD
Bosutinib—CSK—urethra—ureter cancer	0.00474	0.00845	CbGeAlD
Bosutinib—CSNK1A1—urethra—ureter cancer	0.00471	0.0084	CbGeAlD
Bosutinib—MAP2K1—kidney—ureter cancer	0.00469	0.00837	CbGeAlD
Bosutinib—EPHB3—Axon guidance—DCC—ureter cancer	0.00468	0.0107	CbGpPWpGaD
Bosutinib—HCK—urethra—ureter cancer	0.00468	0.00834	CbGeAlD
Bosutinib—CLK1—urethra—ureter cancer	0.00468	0.00834	CbGeAlD
Bosutinib—CSK—kidney—ureter cancer	0.00466	0.00832	CbGeAlD
Bosutinib—CSNK1A1—kidney—ureter cancer	0.00463	0.00826	CbGeAlD
Bosutinib—LRRK2—renal system—ureter cancer	0.00463	0.00826	CbGeAlD
Bosutinib—CLK1—kidney—ureter cancer	0.0046	0.00821	CbGeAlD
Bosutinib—CAMK2G—urethra—ureter cancer	0.00459	0.00819	CbGeAlD
Bosutinib—LRRK2—urethra—ureter cancer	0.00455	0.00812	CbGeAlD
Bosutinib—PTK2B—renal system—ureter cancer	0.00451	0.00805	CbGeAlD
Bosutinib—LRRK2—kidney—ureter cancer	0.00448	0.00799	CbGeAlD
Bosutinib—FES—Axon guidance—DCC—ureter cancer	0.0044	0.01	CbGpPWpGaD
Bosutinib—ROCK1—Apoptosis—DCC—ureter cancer	0.00439	0.01	CbGpPWpGaD
Bosutinib—SIK1—renal system—ureter cancer	0.00437	0.0078	CbGeAlD
Bosutinib—PTK2B—kidney—ureter cancer	0.00436	0.00779	CbGeAlD
Bosutinib—CSNK1E—urethra—ureter cancer	0.00436	0.00778	CbGeAlD
Bosutinib—SIK1—urethra—ureter cancer	0.00429	0.00766	CbGeAlD
Bosutinib—IRAK4—urethra—ureter cancer	0.00429	0.00766	CbGeAlD
Bosutinib—ERBB3—renal system—ureter cancer	0.00428	0.00764	CbGeAlD
Bosutinib—MAP2K2—renal system—ureter cancer	0.00427	0.00763	CbGeAlD
Bosutinib—EPHA4—urethra—ureter cancer	0.00425	0.00758	CbGeAlD
Bosutinib—SIK1—kidney—ureter cancer	0.00423	0.00754	CbGeAlD
Bosutinib—ULK3—urethra—ureter cancer	0.0042	0.00749	CbGeAlD
Bosutinib—MAP2K2—urethra—ureter cancer	0.0042	0.00749	CbGeAlD
Bosutinib—PTK2—Cell-Cell communication—DCC—ureter cancer	0.00418	0.00951	CbGpPWpGaD
Bosutinib—EPHA3—Axon guidance—DCC—ureter cancer	0.00417	0.0095	CbGpPWpGaD
Bosutinib—EPHA5—Axon guidance—DCC—ureter cancer	0.00417	0.0095	CbGpPWpGaD
Bosutinib—ABL2—Axon guidance—DCC—ureter cancer	0.00417	0.0095	CbGpPWpGaD
Bosutinib—PTK2—renal system—ureter cancer	0.00416	0.00741	CbGeAlD
Bosutinib—TBK1—renal system—ureter cancer	0.00416	0.00741	CbGeAlD
Bosutinib—ERBB3—kidney—ureter cancer	0.00414	0.00739	CbGeAlD
Bosutinib—MAP2K2—kidney—ureter cancer	0.00413	0.00737	CbGeAlD
Bosutinib—MAP3K7—urethra—ureter cancer	0.00413	0.00737	CbGeAlD
Bosutinib—CYP3A4—urine—ureter cancer	0.0041	0.00731	CbGeAlD
Bosutinib—PTK2—urethra—ureter cancer	0.00408	0.00728	CbGeAlD
Bosutinib—TBK1—urethra—ureter cancer	0.00408	0.00728	CbGeAlD
Bosutinib—EPHA8—Axon guidance—DCC—ureter cancer	0.00403	0.00916	CbGpPWpGaD
Bosutinib—PTK2—kidney—ureter cancer	0.00402	0.00717	CbGeAlD
Bosutinib—TBK1—kidney—ureter cancer	0.00402	0.00717	CbGeAlD
Bosutinib—RPS6KB1—renal system—ureter cancer	0.004	0.00713	CbGeAlD
Bosutinib—EPHB4—Axon guidance—DCC—ureter cancer	0.00398	0.00906	CbGpPWpGaD
Bosutinib—EPHA4—Axon guidance—DCC—ureter cancer	0.00398	0.00906	CbGpPWpGaD
Bosutinib—RPS6KB1—urethra—ureter cancer	0.00393	0.00701	CbGeAlD
Bosutinib—FGR—urethra—ureter cancer	0.0039	0.00696	CbGeAlD
Bosutinib—LCK—urethra—ureter cancer	0.0039	0.00696	CbGeAlD
Bosutinib—AXL—urethra—ureter cancer	0.00389	0.00694	CbGeAlD
Bosutinib—RPS6KB1—kidney—ureter cancer	0.00386	0.0069	CbGeAlD
Bosutinib—EPHB2—Axon guidance—DCC—ureter cancer	0.00386	0.00877	CbGpPWpGaD
Bosutinib—EPHB4—renal system—ureter cancer	0.00378	0.00675	CbGeAlD
Bosutinib—SLK—urethra—ureter cancer	0.00374	0.00668	CbGeAlD
Bosutinib—EPHB4—urethra—ureter cancer	0.00372	0.00663	CbGeAlD
Bosutinib—FYN—renal system—ureter cancer	0.0037	0.00661	CbGeAlD
Bosutinib—PRKCQ—Axon guidance—DCC—ureter cancer	0.00368	0.00836	CbGpPWpGaD
Bosutinib—EPHB4—kidney—ureter cancer	0.00366	0.00652	CbGeAlD
Bosutinib—EPHA2—urethra—ureter cancer	0.00364	0.0065	CbGeAlD
Bosutinib—FYN—urethra—ureter cancer	0.00364	0.00649	CbGeAlD
Bosutinib—PTK2—Apoptosis—DCC—ureter cancer	0.00363	0.00826	CbGpPWpGaD
Bosutinib—FYN—kidney—ureter cancer	0.00358	0.00639	CbGeAlD
Bosutinib—MAP3K3—urethra—ureter cancer	0.00356	0.00634	CbGeAlD
Bosutinib—MAP4K5—urethra—ureter cancer	0.00356	0.00634	CbGeAlD
Bosutinib—YES1—renal system—ureter cancer	0.00334	0.00596	CbGeAlD
Bosutinib—EPHB3—Developmental Biology—DCC—ureter cancer	0.00334	0.0076	CbGpPWpGaD
Bosutinib—STK10—renal system—ureter cancer	0.00331	0.00591	CbGeAlD
Bosutinib—TAOK3—renal system—ureter cancer	0.0033	0.00589	CbGeAlD
Bosutinib—YES1—urethra—ureter cancer	0.00328	0.00586	CbGeAlD
Bosutinib—EPHA2—Axon guidance—DCC—ureter cancer	0.00325	0.00739	CbGpPWpGaD
Bosutinib—TAOK3—urethra—ureter cancer	0.00324	0.00578	CbGeAlD
Bosutinib—YES1—kidney—ureter cancer	0.00323	0.00577	CbGeAlD
Bosutinib—SRC—renal system—ureter cancer	0.00322	0.00574	CbGeAlD
Bosutinib—STK10—kidney—ureter cancer	0.0032	0.00571	CbGeAlD
Bosutinib—TAOK3—kidney—ureter cancer	0.00319	0.00569	CbGeAlD
Bosutinib—FES—Developmental Biology—DCC—ureter cancer	0.00314	0.00715	CbGpPWpGaD
Bosutinib—SRC—kidney—ureter cancer	0.00311	0.00555	CbGeAlD
Bosutinib—FYN—Cell-Cell communication—DCC—ureter cancer	0.00303	0.00689	CbGpPWpGaD
Bosutinib—EPHA5—Developmental Biology—DCC—ureter cancer	0.00298	0.00678	CbGpPWpGaD
Bosutinib—EPHA3—Developmental Biology—DCC—ureter cancer	0.00298	0.00678	CbGpPWpGaD
Bosutinib—ABL2—Developmental Biology—DCC—ureter cancer	0.00298	0.00678	CbGpPWpGaD
Bosutinib—MAP2K5—urethra—ureter cancer	0.00291	0.00518	CbGeAlD
Bosutinib—EPHA8—Developmental Biology—DCC—ureter cancer	0.00287	0.00654	CbGpPWpGaD
Bosutinib—EPHB4—Developmental Biology—DCC—ureter cancer	0.00284	0.00647	CbGpPWpGaD
Bosutinib—EPHA4—Developmental Biology—DCC—ureter cancer	0.00284	0.00647	CbGpPWpGaD
Bosutinib—CSF1R—urethra—ureter cancer	0.00284	0.00506	CbGeAlD
Bosutinib—EPHB2—Developmental Biology—DCC—ureter cancer	0.00275	0.00626	CbGpPWpGaD
Bosutinib—PRKCQ—Developmental Biology—DCC—ureter cancer	0.00262	0.00597	CbGpPWpGaD
Bosutinib—PDGFRB—renal system—ureter cancer	0.00256	0.00457	CbGeAlD
Bosutinib—PDGFRB—urethra—ureter cancer	0.00252	0.00449	CbGeAlD
Bosutinib—PDGFRB—kidney—ureter cancer	0.00248	0.00442	CbGeAlD
Bosutinib—ROCK1—Axon guidance—DCC—ureter cancer	0.00244	0.00554	CbGpPWpGaD
Bosutinib—EPHA2—Developmental Biology—DCC—ureter cancer	0.00232	0.00527	CbGpPWpGaD
Bosutinib—ABL1—renal system—ureter cancer	0.00228	0.00407	CbGeAlD
Bosutinib—ABL1—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00225	0.00512	CbGpPWpGaD
Bosutinib—ABL1—urethra—ureter cancer	0.00224	0.004	CbGeAlD
Bosutinib—SRC—Cell-Cell communication—DCC—ureter cancer	0.00223	0.00508	CbGpPWpGaD
Bosutinib—MAP2K1—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00221	0.00503	CbGpPWpGaD
Bosutinib—ABL1—kidney—ureter cancer	0.00221	0.00394	CbGeAlD
Bosutinib—PTK2—Axon guidance—DCC—ureter cancer	0.00201	0.00458	CbGpPWpGaD
Bosutinib—YES1—Axon guidance—DCC—ureter cancer	0.00199	0.00452	CbGpPWpGaD
Bosutinib—EGFR—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00192	0.00437	CbGpPWpGaD
Bosutinib—ROCK1—Developmental Biology—DCC—ureter cancer	0.00174	0.00396	CbGpPWpGaD
Bosutinib—SRC—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00164	0.00373	CbGpPWpGaD
Bosutinib—MAP2K2—Axon guidance—DCC—ureter cancer	0.00155	0.00353	CbGpPWpGaD
Bosutinib—LYN—Axon guidance—DCC—ureter cancer	0.00148	0.00337	CbGpPWpGaD
Bosutinib—ABL1—Axon guidance—DCC—ureter cancer	0.00147	0.00335	CbGpPWpGaD
Bosutinib—FYN—Axon guidance—DCC—ureter cancer	0.00146	0.00332	CbGpPWpGaD
Bosutinib—MAP2K1—Axon guidance—DCC—ureter cancer	0.00145	0.0033	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—DCC—ureter cancer	0.00144	0.00327	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—DCC—ureter cancer	0.00142	0.00322	CbGpPWpGaD
Bosutinib—EGFR—Axon guidance—DCC—ureter cancer	0.00126	0.00287	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—DCC—ureter cancer	0.00111	0.00252	CbGpPWpGaD
Bosutinib—SRC—Axon guidance—DCC—ureter cancer	0.00107	0.00244	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—DCC—ureter cancer	0.00106	0.0024	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—DCC—ureter cancer	0.00105	0.00239	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—DCC—ureter cancer	0.00104	0.00237	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—DCC—ureter cancer	0.00103	0.00235	CbGpPWpGaD
Bosutinib—CYP3A4—renal system—ureter cancer	0.001	0.00179	CbGeAlD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—ureter cancer	0.00097	0.00221	CbGpPWpGaD
Bosutinib—CYP3A4—kidney—ureter cancer	0.000969	0.00173	CbGeAlD
Bosutinib—EGFR—Developmental Biology—DCC—ureter cancer	0.000899	0.00204	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—DCC—ureter cancer	0.000767	0.00174	CbGpPWpGaD
Bosutinib—ABCB1—renal system—ureter cancer	0.00071	0.00127	CbGeAlD
Bosutinib—ABCB1—urethra—ureter cancer	0.000697	0.00124	CbGeAlD
Bosutinib—ABCB1—kidney—ureter cancer	0.000686	0.00122	CbGeAlD
